Literature DB >> 29278841

Patient education-level affects treatment allocation and prognosis in esophageal- and gastroesophageal junctional cancer in Sweden.

Gustav Linder1, Fredrik Sandin2, Jan Johansson3, Mats Lindblad4, Lars Lundell4, Jakob Hedberg5.   

Abstract

BACKGROUND: Low socioeconomic status and poor education elevate the risk of developing esophageal- and junctional cancer. High education level also increases survival after curative surgery. The present study aimed to investigate associations, if any, between patient education-level and treatment allocation after diagnosis of esophageal- and junctional cancer and its subsequent impact on survival.
METHODS: A nation-wide cohort study was undertaken. Data from a Swedish national quality register for esophageal cancer (NREV) was linked to the National Cancer Register, National Patient Register, Prescribed Drug Register, Cause of Death Register and educational data from Statistics Sweden. The effect of education level (low; ≤9 years, intermediate; 10-12 years and high >12 years) on the probability of allocation to curative treatment was analyzed with logistic regression. The Kaplan-Meier-method and Cox proportional hazard models were used to assess the effect of education on survival.
RESULTS: A total of 4112 patients were included. In a multivariate logistic regression model, high education level was associated with greater probability of allocation to curative treatment (adjusted OR: 1.48, 95% CI: 1.08-2.03, p = 0,014) as was adherence to a multidisciplinary treatment-conference (adjusted OR: 3.13, 95% CI: 2.40-4.08, p < 0,001). High education level was associated with improved survival in the patients allocated to curative treatment (HR: 0.82, 95% CI: 0.69-0.99, p = 0,036). DISCUSSION: In this nation-wide cohort of esophageal- and junctional cancer patients, including data regarding many confounders, high education level was associated with greater probability of being offered curative treatment and improved survival.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Curative treatment; Education level; Esophageal cancer; Inequality in cancer treatment; Multi-disciplinary conference

Mesh:

Year:  2018        PMID: 29278841     DOI: 10.1016/j.canep.2017.12.008

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  7 in total

1.  Associations of Education Level With Survival Outcomes and Treatment Receipt in Patients With Gastric Adenocarcinoma.

Authors:  Jiaxuan Xu; Shuhui Du; Xiaoqing Dong
Journal:  Front Public Health       Date:  2022-06-09

2.  Effect of sex on survival after resection of oesophageal cancer: nationwide cohort study.

Authors:  Ji Zhang; Rino Bellocco; Weimin Ye; Jan Johansson; Magnus Nilsson; Mats Lindblad
Journal:  BJS Open       Date:  2022-05-02

3.  Burden of in-hospital care in oesophageal cancer: national population-based study.

Authors:  G Linder; F Klevebro; D Edholm; J Johansson; M Lindblad; J Hedberg
Journal:  BJS Open       Date:  2021-05-07

4.  Nationwide study of the impact of D2 lymphadenectomy on survival after gastric cancer surgery.

Authors:  C-H Kung; J A Tsai; L Lundell; J Johansson; M Nilsson; M Lindblad
Journal:  BJS Open       Date:  2020-03-04

5.  Improvements in esophageal and gastric cancer care in Sweden-population-based results 2007-2016 from a national quality register.

Authors:  M Jeremiasen; G Linder; J Hedberg; L Lundell; O Björ; M Lindblad; J Johansson
Journal:  Dis Esophagus       Date:  2020-03-16       Impact factor: 3.429

6.  Superior socioeconomic status in patients with type 2 diabetes having gastric bypass surgery: a case-control analysis of 10 642 individuals.

Authors:  Magnus Sundbom; Stefan Franzén; Johan Ottosson; Ann-Marie Svensson
Journal:  BMJ Open Diabetes Res Care       Date:  2020-01

7.  Education level as a predictor of survival in patients with multiple myeloma.

Authors:  Limei Xu; Xiuju Wang; Xueyi Pan; Xiaotao Wang; Qing Wang; Bingyi Wu; Jiahui Cai; Ying Zhao; Lijuan Chen; Wuping Li; Juan Li
Journal:  BMC Cancer       Date:  2020-08-08       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.